Publications, Pharmaceutical

Investigating Breathable HPV-L2 Dry Powder Vaccine using GLA as Amphiphilic Lubricant and Immune-adjuvant

Dry powder respirable vaccines combine the advantage of high patient acceptability with a lack of any requirement for cold chain storage, an important logistical and economic benefit.

Download Publication
10 Dec 2021

This paper describes a proof-of-concept validation of a dry powder human papillomavirus (HPV) respirable vaccine developed using a particle engineering approach. A key characteristic of the developed formulation is the application of glucopyranosyl lipid A (GLA) to the surface of vaccine particles to simultaneously improve aerosolization performance and recognition by the lung immune cells. Extensive in vitro characterization of the resulting formulation was carried out along with in vivo tests to determine lung deposition behavior, following intratracheal administration to mice. A subsequent short-term immunization study provided evidence of an immune response comparable to that achieved via subcutaneous delivery.

Learn more about Aptar Pharma Expertise
in Pulmonary Drug Delivery

Find Out More

This Might Also Be of Interest

21 May 2025

Low GWP pMDI Q&A with Aptar’s ZEN30 Futurity™ Valve Solution

Publications, Pharmaceutical, Brand Differentiation, Market Insights, Product Solutions, Sustainability, Drug Delivery Innovations

Read More
19 May 2025

Innovations in Pulmonary Care: DPI and NPLI Lead the Way

Publications, Pharmaceutical, Innovation & Insights, Drug Delivery Innovations, Market Insights, Product Solutions

Read More
23 Apr 2025

Spotlight on Emissions Reductions for A Lower CO2 Footprint in Pharmaceutical Packagi...

Publications, Pharmaceutical, Sustainability, Brand Differentiation, Market Insights, Product Solutions

Read More
22 Oct 2024

Advanced Analysis of Dry Powder Inhaler Formulations for Bioequivalence

Publications, Pharmaceutical, Market Insights, Product Solutions, Drug Delivery Innovations

Read More
1 2 3 20

Request Access

Close

Requesting access to Investigating Breathable HPV-L2 Dry Powder Vaccine using GLA as Amphiphilic Lubricant and Immune-adjuvant.

  • This field is hidden when viewing the form
  • This field is hidden when viewing the form
  • This field is hidden when viewing the form
  • This field is hidden when viewing the form
  • This field is hidden when viewing the form
  • This field is hidden when viewing the form
  • This field is hidden when viewing the form
  • This field is for validation purposes and should be left unchanged.
Back To Top